Showing Results for
- Academic Journals (8)
Search Results
- 8
Academic Journals
- 8
- Search Terms:ISSN: 14622416AndISSN: 17448042AndVolume Number: 6AndIssue Number: 4AndStart Page: 383AndDate: 2005 Revise Search
- 1From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Simone Mocellin [[dagger]] 1 , Francesco M Marincola 2 Keywords: clinical trials; functional genomics; high-throughput technology; microarray; pharmacogenomics; proteomics One of the pillars on which...
- 2From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Simon T Bennett, Colin Barnes, Anthony Cox, Lisa Davies, Clive Brown [[dagger]] 1 Keywords: cloned single molecule array; genetic variation; Re-sequencing; sequencing by synthesis; single molecule...
- 3From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Chin-Chuan Hung 1 2 , John Jen Tai 3 , Chun-Jung Lin 2 , Ming-Jen Lee 4 5 , Horng-Huei Liou [1,4[dagger]] 1 4 Keywords: epilepsy; haplotype; linkage disequilibrium; MDR1; multi-drug resistance...
- 4From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Petra Ross-Macdonald 1 Keywords: chemical biology; chemical genetics; mechanism of action; Molecular Libraries Initiative; reverse genetics; RNAi; small molecule; target identification Sometimes, the...
- 5From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedNew findings presented at the American Society of Clinical Oncology (ASCO) Annual Meeting show that neuroblastoma patients who have a loss of heterozygosity (LOH) on chromosome 11q are more likely to have a worse...
- 6From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Su-Jun Lee [[dagger]] 1 , Joyce A Goldstein 1 Keywords: CYP3A4; CYP3A5; genotyping; metabolism; pharmacogenetics; pharmacogenomics; polymorphisms; single nucleotide polymorphisms Cytochrome P450...
- 7From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-Reviewed
Pharmacogenetics and pharmacogenomics instruction in schools of pharmacy in the USA: is it adequate?
Author(s): David A Latif 'Schools of pharmacy should continue to embrace the opportunities presented by pharmacogenetics and pharmacogenomics.' The provision of pharmaceutical care has been incorporated into the... - 8From: Pharmacogenomics. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Jiri Aubrecht [[dagger]] 1 , Ebru Caba Keywords: DNA damage; gene expression; genotoxicity; genotoxic stress response; risk assessment; toxicogenomics Chromosome damage and mutations in DNA are...